Teva sells Quebec plant to Halo; Visionspect launches industry's first contract visual inspection device;

> Royal DSM's DSM Pharmaceutical Products was honored as the best contract manufacturing organization by Biopharma Asia at its Second Annual Biopharma Asia Industry Awards in Singapore. Release

> After an 8-month effort, Teva Pharmaceutical Industries ($TEVA) has sold its Quebec plant to Halo Pharmaceuticals ($HALO), which the latter will use to expand its efforts in contract manufacturing. Article

> San Diego CRO Althea Technologies grabbed the worldwide rights to Allena Pharmaceuticals' Hyperoxaluria portfolio. Release

> GE Healthcare ups its molecular diagnostics game. Article

> Visionspect, a division of DJA Pharma, announced that it completed the industry's first contract visual inspection system, which is expected to help clients save operating costs. Release

Suggested Articles

California clinical trial artificial intelligence startup Saama Technologies has teamed up with Big Pharma Pfizer.

Contract research organization Worldwide Clinical Trials has hired Mike Mencer as EVP and general manager of its early-phase services.

Getting the right patients into the right trial at the right time, and keeping them there, is a tough gig.